Interferon alpha (IFNα) is the only approved immunomodulatory drug for chronic hepatitis B treatment, exerting its antiviral effects through the induction of interferon-stimulated genes (ISGs). Here, IFNA2 is linked to chronic hepatitis B virus infection.